| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.17B | +8.2% |
| Cost of Revenue | $8.46B | +9.0% |
| Gross Profit | $714.3M | -0.5% |
| R&D Expense | $9.2M | +3.4% |
| SG&A Expense | $495.5M | +4.5% |
| Operating Income | $223.0M | -20.5% |
| Interest Expense | $66.5M | -7.9% |
| Pre-tax Income | $168.2M | -29.8% |
| Income Tax | $71.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $267.9M | -18.8% |
| Short-term Investments | $6.4M | +6.6% |
| Accounts Receivable | $539.8M | +14.0% |
| Inventory | $509.3M | +18.4% |
| Current Assets | $1.75B | -7.1% |
| Total Assets | $4.40B | -1.1% |
| Current Liabilities | $1.49B | -6.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Financing Cash Flow | -$151.3M | +36.4% |
| -6.1% |
| Net Income | $51.3M | -59.1% |
| EPS (Basic) | $0.54 | -59.1% |
| EPS (Diluted) | $0.53 | -59.8% |
| Long-term Debt |
| $829.4M |
| -7.1% |
| Total Liabilities | $2.89B | -3.9% |
| Stockholders' Equity | $1.36B | +5.5% |